Hepion Pharmaceuticals, Inc. (CTRVP)
LECTRA: First half 2025: stable revenues and limited decline in EBITDA in a context of increased volatility in Q2
LECTRA: First half 2025: stable revenues and limited decline in EBITDA in a context of increased volatility in Q2
There are no comments here yet...